M
Mahwish Arooj
Researcher at University of Lahore
Publications - 23
Citations - 829
Mahwish Arooj is an academic researcher from University of Lahore. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 6, co-authored 17 publications receiving 311 citations.
Papers
More filters
Journal ArticleDOI
Advantages, limitations and recommendations for online learning during covid-19 pandemic era
TL;DR: The perception of teachers and students regarding its advantages, limitations and recommendations are explored and the use of online learning in medical and dental institutes in Pakistan is supported, considering its various advantages.
Journal Article
New Possibilities in Hepatocellular Carcinoma Treatment
Mahmood Rasool,Sana Rashid,Mahwish Arooj,Shakeel Ahmed Ansari,Khalid Mahmud Khan,Arif Malik,Muhammad Imran Naseer,Sara Zahid,Abdul Manan,Muhammad Asif,Zarish Razzaq,Sadia Ashraf,Mahmood Husain Qazi,Zafar Iqbal,Siew Hua Gan,Mohammad Amjad Kamal,Ishfaq Ahmed Sheikh +16 more
TL;DR: In this article, the authors provided an analysis of the above parameters in the management of HCC, including the staging system, serological testing and diagnostic imaging, and the most encouraging specific serological marker for HCC is alpha fetoprotein (AFP), which, along with ultrasonography, has improved earlier detection of the HCC.
Journal ArticleDOI
Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
Zahid Hussain,Mahwish Arooj,Arif Malik,Fahad Hussain,Hassan Safdar,Shahzeb Khan,Muhammad Sohail,Manisha Pandey,Hira Choudhury,Hnin Ei Thu +9 more
TL;DR: The current review presents a comprehensive overview of nanocarrier aided multi-drug therapies alongside recent advancements, future prospects, and the pivotal requirements for interdisciplinary research.
Journal Article
Potential role of amino acids in pathogenesis of schizophrenia
TL;DR: The relationship of perturb amino acid levels with the biological basis and pathophysiology of schizophrenia is an important area to be further explored for effective management of schizophrenic patients.
Journal ArticleDOI
Molecular Characterization of FLT3 Mutations in Acute Leukemia Patients
Mariam Ishfaq,Arif Malik,Mariam Faiz,Ishfaq A. Sheikh,Muhammad Asif,Muhammad Nasrullah Khan,Muhammad Saeed Qureshi,Sara Zahid,Abdul Manan,Mahwish Arooj,Mahmood Husain Qazi,Adeel G. Chaudhary,Mohammed H. Al-Qahtani,Mahmood Rasool +13 more
TL;DR: In acute myeloid leukemia (AML) FLT3/ITD+ mutation was more prevalent in elderly patients 31-40 age groups, 21-30 and 51-60 age groups respectively, while in acute lymphoblastic leukemia (ALL) statistically no significant relationship was found between clinical features and FLT 3/ ITD positivity (p>0.05).